by IgNS | Jul 17, 2019 | Latest News
Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Activity Overview: The administration of immunoglobulin (Ig) has become common practice in the treatment of patients with immunodeficiencies, and, more recently, in other...
by IgNS | Feb 8, 2019 | Uncategorized
by IgNS | Jan 29, 2019 | Uncategorized
IgNS mandates a three-year recertification period to ensure that the IgCN is exposed to developments within the field. This assures the public that the IgCN provides the best possible infusion therapy because they have kept abreast of technological and clinical...
by IgNS | Jan 16, 2019 | Uncategorized
All presenting authors must be registered as an attendee at IgNS 2019 Conference. Before submitting your abstract please read the following submission guidelines: 1. All abstracts are required to convey relevance to the IgNS mission, vision and values. IgNS is...
by IgNS | Nov 6, 2018 | Latest News
Immunoglobulin National Society (IgNS) is pleased to announce a two-year corporate sponsorship agreement with Managed Health Care Associates, Inc., a health care services and software company based in Florham Park, NJ. This sponsorship agreement is part of both...